Ventris Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Ventris Medical is a commercial-stage biologics company addressing a critical challenge in spinal and orthopedic surgery: bone graft containment and migration. Its core innovation is the Backpack®, a resorbable, perforated collagen pouch that holds graft material in place, promoting optimal cellular flow and integration. Led by an experienced founder with a successful track record of company creation and exits in the biologics space, Ventris leverages a vertically integrated supply chain to offer a suite of allograft, synthetic, and bioactive products aimed at improving surgical reproducibility and patient care.

OrthopedicsSpinal Surgery

Technology Platform

The Backpack® Bone Graft Containment System: a resorbable, perforated collagen pouch platform designed to hold bone graft material in place during spinal and orthopedic fusion procedures, preventing migration and promoting cellular ingrowth and integration.

Opportunities

The primary opportunity is addressing the significant clinical problem of bone graft migration in spinal fusion, a common cause of surgical failure, with a dedicated FDA-approved device.

The aging population and rising rates of spinal procedures create a large and growing market for innovative solutions that improve surgical reproducibility and patient outcomes.

Risk Factors

Key risks include intense competition from large, established medical device companies, the challenge of driving surgeon adoption and changing clinical practice, and the regulatory and supply chain complexities associated with processing human allograft tissues.

Competitive Landscape

Ventris competes in the crowded spine biologics and devices market dominated by giants like Medtronic, Stryker, and Johnson & Johnson DePuy Synthes. Its differentiation is its specific focus on graft containment rather than just graft material, competing against off-label techniques and other mesh/cage products not specifically designed for this purpose.

More companies in Biologics / Biosimilars →More companies in United States →